Tudor Investment Corp
ATXS

Tudor Investment Corp’s Astria Therapeutics ATXS Stock Holding History

Tudor Investment Corp’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-875,000
Closed -$11.5M – 3593
2025
Q4 		$11.5M Buy
+875,000
New +$10.5M 0.02% 660

Tudor Investment Corp's ATXS Position: Q1 2026 in Review

Tudor Investment Corp sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 875,000 shares — an estimated $11.5M sold.

Tudor Investment Corp first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $11.5M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

  • Tudor Investment Corp reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 875,000 Astria Therapeutics shares in Q1 2026, an estimated $11.5M.
  • Tudor Investment Corp first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
  • Tudor Investment Corp's Astria Therapeutics position peaked at $11.5M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.